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Abstract 
Structure activity relationship (SAR) studies are performed in order to identify the core structure 
that is responsible for the biological activity of an organic molecule. Recently, we have 
synthesized a drug prototype which contains several functional groups, such as an alcohol, an 
ester, a fluorine, and an aromatic ring. While studying in vivo toxicity of this molecule in 
zebrafish (Danio rerio) embryo, we observed that it has a unique biological activity that causes a 
sudden inactivity in embryo movement. Continued investigation revealed that this molecule 
blocks sodium channels in neurons causing a temporary anesthesia in Danio rerio embryo. The 
biological activity in zebrafish was performed with Dr. Sittaramane. We have also observed that 
after transferring the embryo to fresh water, the embryo resumed normal behavior. As our next 
step, we would like to synthesize a variety of structural analogs and determine their activity. The 
ultimate goal of this project was to develop effective methods of synthesizing various molecules 
that have one of the functional groups removed in order to identify its role in biological activity. 
All products and intermediates will be fully analyzed using NMR, IR and Mass spectrometer 
analysis. Further structural modifications may be required depending on the activity findings. 
After successful synthesis of the proposed molecules, Dr. Sittaramane and I performed in vivo 
activity determination.  
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Introduction  
Quinolines are naturally occurring structures that typically act as structural subunits of much 
larger, more complex molecules1. Further, quinoline derivatives are known to exhibit many 
medical properties. For instance, quinoline derivatives are currently being utilized as a method to 
treat and prevent malaria2.  
 There are many compounds that are known to possess sedative properties. Specifically, 
anesthetics are compounds which prevent nerves from communicating any sensations that they 
are exposed to. These anesthetics are known to alter how the blood-brain barrier (BBB) 
functions4. The BBB, endothelial tight junction between capillaries and the CNS, is essential in 
maintaining homeostasis throughout the central nervous system5. One known method of 
interfering with the BBB is to affect the function sodium channels, as seen in lidocaine6. This 
works because sodium channels are known to initiate and propagate action potentials in muscles; 
if no action potential is initiated or propagated, then no sensation will be registered by the brain7. 
Structure-activity relationship studies are utilized to determine the role between the 
structure of a specific compound and its biological activity. In this case, we have a compound, 
4,4,4-trifluoro-3-hydroxy-3-(quinolin-8-chloro-2-ylmethyl)butanoate, which is biologically 
active. This was discovered while studying in vivo toxicity of this molecule in zebrafish (Danio 
rerio) embryo, we observed that it has a unique biological activity that causes a sudden inactivity 
in embryo movement. Danio rerio was chosen as a model organism due to its genetic similarity 
to humans and its similar motor system3. Continued investigation revealed that this molecule 
blocks sodium channels in neurons causing a temporary anesthesia in Danio rerio embryo. We 
have also observed that after transferring the embryo to fresh water, the embryo resumed normal 
behavior.  
The goal of this project is to determine which aspects of the chemical structure of our 
compound are biologically active and if we can alter it to make it more effective. In order to 
accomplish this, various analogs will be synthesized by altering key functional groups. 
Specifically, the changes will involve the removal of an ethyl, the removal of a chlorinated 
aromatic ring, the addition of chlorine, or the addition of fluorine. These newly synthesized 
compounds will then be tested on Danio rerio embryo and the results will be statistically 
evaluated. 
Results and discussion 
Our original goal was to determine which functional groups on JF-1-1 contributed to the 
sedative phenotype which was characterized in Danio rerio. In order to accomplish this, our 
study synthesized structural analogs of JF-1-1 to help determine which functional groups played 
a role in the phenotype. To begin this test, five distinct compounds (JF-1-1, compound 1, 










1 altered JF-1-1 by replacing an Ethyl with an OH group, 3 altered JF-1-1 by removing a 
chlorobenzene, 6 altered JF-1-1 by replacing a hydroxide with a chlorine, and 8 altered JF-1-1 
by replacing a hydroxide with a fluorine. Over the course of the next several weeks, various 
assays were conducted on Danio rerio. For these assays, Danio rerio were exposed to the control 
condition (1µM DMSO suspended in embryonic medium (E3)) or the experimental condition 
(6.7 µM of compound in DMSO suspended E3) for twelve hours prior to data collection. Data 
were collected using a DanioVision in conjunction with EthoVision XT software to monitor the 
total distance moved (mm) by Danio rerio and the mean amount of activity (moving parts of 
body without physical distance traveled) in two cycles, a cycle exposed to white light and a cycle 
exposed to no light. Only compounds 6 and JF-1-1 (6.7 µM in DMSO suspended E3) were 
statistically different compared to the control (1µM DMSO in E3). 
Conclusion 
In summary, our experimentation yielded that compound 6 (4,4,4-trifluoro-3-chloro-3-(quinolin-
8-chloro-2-ylmethyl)butanoate) and JF-1-1 (4,4,4-trifluoro-3-hydroxy-3-(quinolin-8-chloro-2-
ylmethyl)butanoate) were statistically significant in terms of producing a sedative phenotype in 
Danio rerio at a dosage of 6.7 µM. From this, it can be inferred that functional groups such as 4-
chlorobenzene, EtOH, CF3, etc. were all crucial for producing the observed phenotype. Future 
experimentation can build upon this framework to further determine which functional groups 
play the largest role in the effectiveness of these quinoline derivatives. Further testing needs to 
be done with compound 6 to ensure that it is statistically significant at producing the sedative 
phenotype with a large sample size. This experimentation paves the way for further investigation 
into quinoline derivatives being used as painkillers or sedatives rather than using the traditional 
medication of today. 
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Appendix: Experimental Procedure and Product Characterization 
Experimental Procedure 
JF-1-1 (4,4,4-trifluoro-3-hydroxy-3-(quinolin-8-chloro-2-ylmethyl)butanoate) (35mg) was added 
to a pressure tube along with 2 mL of methanol, potassium hydroxide (56 mg) and 500µL of 
water. The reaction was then left to stir for 12 hours at room temperature. After the reaction was 
complete, the product was added to a separatory funnel along with ethyl acetate to isolate the 
organic layer. The resulting mixture was then passed over anhydrous sodium sulfate before 
utilizing a Buchi RotaVapor R-200 to concentrate product. This product was then allowed to sit 
under a vacuum overnight to allow for further concentration. The product was then verified by 







1H NMR (250 MHz, CDCl3), δ (ppm) 8.16 (d, J = 8.35 Hz, 1H), 7.81 (d, J = 7.50 Hz, 1H), 7.72 
(d, J = 7.50 Hz, 1H),7.45 (t, J = 8.35 Hz, 1H), 7.38 (d, J = 8.35 Hz, 1H), 7.07 (s, 1H), 4.22 







1H NMR (250 MHz, CDCl3), δ (ppm) 8.29 (d, J = 8.56 Hz, 1H), 7.88 (d, J = 7.69 Hz, 1H), 7.79 





1H NMR (250 MHz, CDCl3), δ (ppm) 8.43 (d, J = 4.86 Hz, 1H), 7.65 (t, J = 8.04 Hz, 1H), 7.19 
(m, 2H), 6.52 (s, 1H), 4.21 (quart, J = 7.04 Hz, 2H), 3.51 (d, J = 14.80 Hz, 1H), 3.32 (d, J = 





1H NMR (250 MHz, CDCl3), δ (ppm) 8.48 (d, J = 9.0 Hz, 1H), 7.86 (t, J = 8.0, 1H), 7.74 (m, 






1H NMR (250 MHz, CDCl3), δ (ppm) 8.18 (d, J = 8.40 Hz, 1H), 7.86 (d, J = 7.55 Hz, 1H), 7.80-
7.67 (m, 4H), 87.56 (d, J = 7.92 Hz, 1H), 3.94 (quart, J = 7.47 Hz, 2H), 2.81 (s, 1H) 
  
